About Team Pleryon
The Pleryon team is comprised of exceptional individuals with rich experience in innovation, product development, medical affairs and entrepreneurship. Our team works closely together, combining our expertise in biomaterial sciences, drug delivery, product development, and medicine to achieve our mission of developing novel polymer-based therapeutics to treat complex diseases.
Management Team
Advisors
Scientia Professor at UNSW Sydney, leader in ocular surface diseases
Professor Fiona Stapleton
PhD, MCOptom, FAAO
Scientia Professor at UNSW Sydney, leader in ocular surface diseases
Prof. Ali Guermazi
MD, PhD
Professor of Radiology and Medicine at Boston University, leader in osteoarthritis
Prof. Lyndon Jones
DSc, FCOptom, FAAO
University Professor at the University of Waterloo, leader in ocular surface diseases
Prof. David Hunter
PhD, FRACP (Rheum)
Chair of Rheumatology at University of Sydney, leader in osteoarthritis
Prof. Robert Langer
ScD
Institute Professors at MIT, leader in biomaterials and drug delivery
Board Members
Yu Yu, PhD
Founder and CEO
Ying Chau
Cofounder and CSO
Junhong Li
Lapam Captital